SCHEMBL155779

SCHEMBL155779

Oc1ccc(SCCc2ccccc2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 3/20 0.59
MAOB P27338 3/20 0.59
CYP1A2 P05177 1/20 0.58
CYP3A4 P08684 1/20 0.58
CYP2D6 P10635 1/20 0.58
CYP2C9 P11712 1/20 0.58
CYP2C19 P33261 1/20 0.58
HIF1A Q16665 1/20 0.58
CA12 O43570 1/20 0.56
CA1 P00915 1/20 0.56
CA2 P00918 1/20 0.56
CA7 P43166 1/20 0.56
CA13 Q8N1Q1 1/20 0.56
HDAC1 Q13547 1/20 0.51
GRIN2A Q12879 1/20 0.51
GRIN2B Q13224 1/20 0.51
MCL1 Q07820 2/20 0.50
BCL2A1 Q16548 2/20 0.50
ALDH1A1 P00352 1/20 0.50
MAPK1 P28482 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6564283 0.94 CYP1A2 (0.61) MAOAMAOBCYP1A2CYP3A4CYP2D6
SCHEMBL3234313 0.91 ESR1 (0.56) MAOAMAOBCYP1A2CYP3A4CYP2D6
SCHEMBL10637449 0.91 ESR1 (0.56) MAOAMAOBCYP1A2CYP3A4CYP2D6
SCHEMBL7779176 0.87 PLA2G4B (0.54) MAOAMAOBCYP1A2CYP3A4CYP2D6
SCHEMBL10407467 0.85 ALDH1A1 (0.71) CYP1A2CYP3A4CYP2D6CYP2C9CYP2C19
SCHEMBL223719 0.84 CYP1A2 (0.76) MAOAMAOBCYP1A2CYP3A4CYP2D6
SCHEMBL28642267 0.82 IDO1 (0.47) MAOAMAOBCYP1A2CYP2D6CYP2C19
SCHEMBL5215733 0.82 IDO1 (0.47) MAOAMAOBCYP1A2CYP2D6CYP2C19
SCHEMBL338116 0.81 MAOA (0.58) MAOAMAOBCYP1A2CYP2C19HIF1A
SCHEMBL10407904 0.79 NR1H2 (0.55) CYP3A4HIF1ACA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575234-B2 Ink composition, and method of forming pattern, color filter and method of preparing color filter using the same SAMSUNG DISPLAY CO., LTD. (KR) 2013-11-05 US claimed
US-20120058273-A1 INK COMPOSITION, AND METHOD OF FORMING PATTERN, COLOR FILTER AND METHOD OF PREPARING COLOR FILTER USING THE SAME DONGWOO FINE-CHEM CO., LTD. (KR) 2012-03-08 US claimed
EP-0882749-B1 Urethane prepolymer, process for producing the same and pressure-sensitive adhesive comprising the same KYOEISHA CHEMICAL CO LTD (JP) 2004-03-24 EP claimed
US-6022907-A POLYESTERURETHANE FROM DIMER ACIDS, REACTIVE END GROUPSA KYOEISHA CHEMICAL CO., LTD. (JP) 2000-02-08 US claimed
EP-0882749-A2 Urethane prepolymer, process for producing the same and pressure-sensitive adhesive comprising the same KYOEISHA CHEMICAL CO., LTD. (JP) 1998-12-09 EP claimed
US-12528925-B2 Prepreg and method for producing prepreg TORAY INDUSTRIES, INC. (JP) 2026-01-20 US disclosed
US-20250362609-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING POLYFUNCTIONAL SULFONIC ACID NISSAN CHEMICAL CORPORATION (JP) 2025-11-27 US disclosed
CN-114341215-B Curable composition 株式会社日本触媒 2024-12-27 CN disclosed
CN-115135407-B Two-layer seamless capsule with water-soluble composition as inner wrapper 富士胶囊股份有限公司 2024-12-20 CN disclosed
CN-117659668-A Low-temperature heat-curable resin composition, anisotropic conductive film, and connection structure 常州德创高新材料科技有限公司 2024-03-08 CN disclosed
WO-2024019064-A1 SILICON-CONTAINING RESIST UNDERLAYER FILM-FORMING COMPOSITION CONTAINING POLYFUNCTIONAL SULFONIC ACID 日産化学株式会社 2024-01-25 WO disclosed
US-20230407024-A1 PREPREG AND METHOD FOR PRODUCING PREPREG TORAY INDUSTRIES, INC. (JP) 2023-12-21 US disclosed
EP-1109831-A2 CYCTOTOXIC PEPTIDES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES ALPHARMA AS (NO) 2001-06-27 EP disclosed
WO-2000012542-A2 CYTOTOXIC LACTOFERRIN DERIVATIVES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES ALPHARMA AS (NO) 2000-03-09 WO disclosed
WO-2000012541-A2 CYTOTOXIC PEPTIDES MODIFIED BY BULKY OR LIPOPHILIC MOIETIES ALPHARMA AS (NO) 2000-03-09 WO disclosed
US-6022907-A POLYESTERURETHANE FROM DIMER ACIDS, REACTIVE END GROUPSA KYOEISHA CHEMICAL CO., LTD. (JP) 2000-02-08 US disclosed
EP-0882749-A2 Urethane prepolymer, process for producing the same and pressure-sensitive adhesive comprising the same KYOEISHA CHEMICAL CO., LTD. (JP) 1998-12-09 EP disclosed
US-4891297-A STORAGE STABILITY, HIGH COLOR DENSITY FUJI PHOTO FILM CO.,LTD. (JP) 1990-01-02 US disclosed
US-4143076-A MERCAPTO PHENOLIC AND ALKYLTHIO PHENOLIC ANTIOXIDANTS THE GOODYEAR TIRE & RUBBER COMPANY (US) 1979-03-06 US disclosed
US-4128530-A Mercapto phenolic and alkylthio phenolic antioxidants THE GOODYEAR TIRE & RUBBER COMPANY (US) 1978-12-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12528925-B2 Prepreg and method for producing prepreg PSMA3, PSMG3, PSMA1 MAOA 3886/4885MAOB 4108/4885CYP1A2 3069/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.